Breaking News Instant updates and real-time market news.

CVS

CVS Health

$86.20

-0.02 (-0.02%)

16:52
10/05/16
10/05
16:52
10/05/16
16:52

CVS Health initiated with a Buy at UBS

Target $107.

  • 13

    Oct

CVS CVS Health
$86.20

-0.02 (-0.02%)

08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.
09/30/16
LEER
09/30/16
NO CHANGE
Target $105
LEER
Outperform
CVS Health price target lowered to $105 on pricing concerns at Leerink
Leerink analyst David Larsen said that after speaking with a PBM and Managed Care specialist and performing an analysis of IMS data he now believes that drug pricing has slowed materially over the past 9 months. Given that conclusion, Larsen is lowering his revenue and EPS estimates for CVS Health for the second half of this year and for 2017 and lowered his price target on CVS shares to $105 from $110. However, he keeps an Outperform rating on the stock, since he is still positive on CVS for the long-term.

TODAY'S FREE FLY STORIES

EWW

iShares MSCI Mexico

$51.44

0.45 (0.88%)

06:12
04/28/17
04/28
06:12
04/28/17
06:12
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLM

Columbia Sportswear

$59.77

0.34 (0.57%)

06:12
04/28/17
04/28
06:12
04/28/17
06:12
Downgrade
Columbia Sportswear rating change  »

Columbia Sportswear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCBFF

Standard Chartered

$9.50

0.11 (1.17%)

, NMR

Nomura

$6.47

0.21 (3.35%)

06:11
04/28/17
04/28
06:11
04/28/17
06:11
Periodicals
Nomura sells Standard Chartered stake valued at almost $500M, Bloomberg says »

Nomura (NMR) is selling a…

SCBFF

Standard Chartered

$9.50

0.11 (1.17%)

NMR

Nomura

$6.47

0.21 (3.35%)

BCS

Barclays

$11.51

0.05 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$918.38

9.09 (1.00%)

06:11
04/28/17
04/28
06:11
04/28/17
06:11
Recommendations
Amazon.com analyst commentary  »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 16

    May

  • 23

    May

UUP

PowerShares DB US Dollar Index Up

$25.60

0.04 (0.16%)

06:11
04/28/17
04/28
06:11
04/28/17
06:11
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:11
04/28/17
04/28
06:11
04/28/17
06:11
Hot Stocks
Host Hotels reports Q1 comparable RevPAR on a constant dollar basis up 3.4% »

Comparable RevPAR on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

UDN

PowerShares DB US Dollar Index Down

$21.10

-0.01 (-0.05%)

06:11
04/28/17
04/28
06:11
04/28/17
06:11
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$15.48

-0.02 (-0.13%)

06:10
04/28/17
04/28
06:10
04/28/17
06:10
Earnings
KBR backs FY17 adj. EPS view of $1.10-$1.40, sees results above midpoint »

Consensus $1.27. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ATHN

athenahealth

$121.45

1.6 (1.34%)

06:09
04/28/17
04/28
06:09
04/28/17
06:09
Recommendations
athenahealth analyst commentary  »

Piper expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 17

    May

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:08
04/28/17
04/28
06:08
04/28/17
06:08
Hot Stocks
Breaking Hot Stocks news story on Host Hotels »

Host Hotels sees FY17 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

WDC

Western Digital

$85.71

1.1 (1.30%)

06:08
04/28/17
04/28
06:08
04/28/17
06:08
Technical Analysis
Western Digital trades sharply higher after earnings beat »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPE

Expedia

$136.20

0.45 (0.33%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Downgrade
Expedia rating change  »

Expedia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 16

    May

SBUX

Starbucks

$61.30

-0.26 (-0.42%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Recommendations
Starbucks analyst commentary  »

Piper still a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

CPN

Calpine

$9.59

-0.33 (-3.33%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Hot Stocks
Calpine sees FY17 adjusted EBITDA $1.8B-$1.95B »

Sees FY17 growth CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.14

0.25 (0.48%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Hot Stocks
MetLife's Kandarian says to invest $1B in efficiency enhancements for 2016-2019 »

MetLife CEO Steve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 13

    Jun

DRAD

Digirad Corp

$5.15

-0.05 (-0.96%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Earnings
Digirad Corp sees FY17 adjusted EPS 10c-15c, consensus 26c »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

AGRX

Agile Therapeutics

$3.28

-0.02 (-0.61%)

06:05
04/28/17
04/28
06:05
04/28/17
06:05
Conference/Events
Agile Therapeutics management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CPN

Calpine

$9.59

-0.33 (-3.33%)

06:05
04/28/17
04/28
06:05
04/28/17
06:05
Earnings
Calpine reports Q1 EPS (16c), consensus (12c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$15.48

-0.02 (-0.13%)

06:04
04/28/17
04/28
06:04
04/28/17
06:04
Earnings
KBR reports Q1 EPS ex-items 28c, consensus 29c »

Reports Q1 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

DRAD

Digirad Corp

$5.15

-0.05 (-0.96%)

06:04
04/28/17
04/28
06:04
04/28/17
06:04
Earnings
Digirad Corp reports Q1 adjusted EPS (1c), consensus 5c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:03
04/28/17
04/28
06:03
04/28/17
06:03
Earnings
Host Hotels sees FY17 EPS 73c-81c, consensus 67c »

Sees FY17 GAAP revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

GIMO

Gigamon

$36.00

-0.6 (-1.64%)

06:03
04/28/17
04/28
06:03
04/28/17
06:03
Downgrade
Gigamon rating change  »

Gigamon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVT

Avnet

$40.86

-3.72 (-8.34%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Downgrade
Avnet rating change  »

Avnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$68.27

0.44 (0.65%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Recommendations
Microsoft analyst commentary  »

Piper an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 09

    May

ZEUS

Olympic Steel

$19.23

-0.64 (-3.22%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Earnings
Olympic Steel reports Q1 EPS 68c, consensus 40c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.